L-glutamic acid di-tert-butyl ester hydrochloride

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: L-glutamic acid di-tert-butyl ester hydrochloride
• 英文别名: L-glutamic acid bis(tert-butyl)ester hydrochloride；Glutamic acid di-tert-butyl ester hydrochloride；L-glutamic acid di-t-butyl ester hydrochloride；glutamic acid di-t-butyl ester hydrochloride；4-Amino-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid hydrochloride；4-amino-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid;hydrochloride
• 化学式: C₉H₁₇NO₄*ClH
• 分子量: 239.699
• InChiKey: RKBSTOCWFXYRNS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.94
• 重原子数：
  15
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  89.6
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  L-glutamic acid di-tert-butyl ester hydrochloride 生成 N-allyl-L-glutamic acid di-tert-butyl ester hydrochloride
  参考文献：
  名称：

  HETEROCYCLIC CARBOXYLIC ACID ESTER DERIVATIVE

  摘要：

  本发明提供了一种具有丝氨酸蛋白酶抑制作用的血糖升高抑制剂，该抑制剂是一种用于肥胖的新型治疗或预防剂。化合物如下式（I）所示，其中每个符号如说明书中所述，或其药学上可接受的盐。

  公开号：

  US20140094489A1

文献信息

• Nicotianamine-Derived Metallophore And Processes For Producing Same
  申请人：Dreyfus Cyril

  公开号：US20120095262A1

  公开（公告）日：2012-04-19

  The invention relates to a nicotianamine derivative and to a process for chemical or enzymatic synthesis thereof. The nicotianamine derivative has the following formula (I). The invention finds use in the pharmacy field in particular.

  该发明涉及一种尼古酸胺衍生物及其化学或酶促合成的方法。该尼古酸胺衍生物具有以下化学式（I）。该发明特别适用于药学领域。
• Pyrimidinyl-glutamic acid derivatives
  申请人：Eli Lilly and Company

  公开号：US05426110A1

  公开（公告）日：1995-06-20

  The present invention provides novel pyrimidinyl-glutamic acid derivatives and intermediates thereto. Further provided are methods for inhibiting dihydrofolate reductase in mammals and for treating susceptible neoplasms in mammals, particularly humans.

  本发明提供了新型嘧啶基谷氨酸衍生物及其中间体。进一步提供了一种在哺乳动物中抑制二氢叶酸还原酶的方法，以及用于治疗哺乳动物中易感的肿瘤，特别是人类的方法。
• Thioglycerol derivatives
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US05506267A1

  公开（公告）日：1996-04-09

  A compound of the invention is represented by the formula: ##STR1## wherein R.sup.1 and R.sup.2 are the same or different, an acyl group; R.sup.3, R.sup.4, R.sup.6 and R.sup.7 are the same or different, hydrogen or an alkyl group; R.sup.5 is hydrogen, an alkyl group or a hydroxyl group which may optionally be protected, or R.sup.4 and R.sup.5 are combined to form a chemical bond; X is a carbonyl group or a sulfonyl group; Y is an amino acid sequence consisting of 1 to 7 amino acid residues which may optionally be protected and having optionally an intervening --SO.sub.2 NH--; n is an integer of 0 to 2, or a salt thereof. The compound or salt thereof of the present invention possesses immunoenhancing activity and platelet reduction recovery activity, and can be used as a prophylactic/therapeutic agent for leukocytopenia in cancer chemotherapy or radiotherapy, as an immunoenhancing agent in bone marrow transplantation therapy and the treatment of osteomyelodysplasia and aplastic anemia, and as a prophylactic/therapeutic agent for thrombocytopenia.

  本发明的化合物由以下公式表示：##STR1##其中R.sup.1和R.sup.2是相同或不同的酰基；R.sup.3、R.sup.4、R.sup.6和R.sup.7是相同或不同的氢原子或烷基基团；R.sup.5是氢原子、烷基基团或可能被保护的羟基基团，或者R.sup.4和R.sup.5结合形成化学键；X是羰基团或磺酰基团；Y是由1至7个氨基酸残基组成的氨基酸序列，可能被保护，可能具有一个可选的--SO.sub.2 NH--插入；n是0至2的整数，或其盐。本发明的该化合物或其盐具有免疫增强活性和血小板减少恢复活性，可用作癌症化疗或放疗中白细胞减少症的预防/治疗剂，用作骨髓移植治疗和骨髓畸形和再生障碍性贫血治疗中的免疫增强剂，以及用作血小板减少症的预防/治疗剂。
• Caged amino acids
  申请人：Laboratory of Molecular Biophotonics

  公开号：US06329546B1

  公开（公告）日：2001-12-11

  The caged amino acid in accordance with the present invention has the structure represented by the following formula 1: where X and Y each represent a halogen atom, an alkyl group, an alkyloxy group, an alkylamino group, or a benzo group; R1 represents a hydrogen atom or an alkyl group; R2 and R3 each represent a hydrogen atom or an alkyl group; A represents an amino acid residue; and M represents a hydrogen atom, an alkali metal, or an alkaline-earth metal.

  根据本发明，被囚禁的氨基酸具有以下式1所表示的结构：其中X和Y分别表示卤素原子、烷基基团、烷氧基团、烷基氨基团或苯基；R1表示氢原子或烷基基团；R2和R3分别表示氢原子或烷基基团；A表示氨基酸残基；M表示氢原子、碱金属或碱土金属。
• NUCLEIC ACID-CONTAINING LIPID NANOPARTICLES
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：EP3275448A1

  公开（公告）日：2018-01-31

  The present invention provides nucleic acid-containing lipid nanoparticles containing a lipid (lipid A) which has a hydrophilic unit having a single quaternary ammonium group, and three independent, optionally substituted hydrocarbon groups, a lipid derivative or fatty acid derivative of a water-soluble polymer, and a nucleic acid.

  本发明提供了含核酸的脂质纳米颗粒，其中含有一种脂质（脂质 A），该脂质具有一个亲水单元，该亲水单元具有一个季铵基团和三个独立的任选取代的烃基、一种水溶性聚合物的脂质衍生物或脂肪酸衍生物以及一种核酸。